Clinical Trial Update: Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)

View source ↗

Summary

A completed study evaluating how to manage synthetic disease-modifying antirheumatic drugs when rheumatoid arthritis patients experience adverse events, intoler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Fundación Andaluza de Reumatología | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-03-08